News

A new tool generates and labels customized aneuploid cells in living tissue to observe the behavior of these cells in ...
BMS will co-develop and co-commercialize BioNTech’s bispecific antibody BNT327 for solid tumors in a deal worth up to $11.1B ...
Insilico plans late-stage trials for rentosertib following positive mid-stage safety and efficacy data for idiopathic ...
The investigational drug demonstrated robust STAT6 degradation in blood and skin that was well tolerated and safe in healthy ...
Combination treatment could also benefit patients with lung, bowel, pancreatic and other solid cancers who don’t respond to ...
Infuzide, a newly synthesized compound, shows potent activity against drug-resistant microbes, offering new hope in the fight against AMR.
A new study found that aged neurons have defects in key proteins that make them vulnerable to molecular stress and neurodegenerative damage.